Several predictors have emerged, reflecting both the tumor immune microenvironment and tumor cell intrinsic features, including PD-L1 expression, tumor mutational burden (TMB), neoantigens, microsatellite instability, tumor-infiltrating immune cells [4], metabolic pathways [5], and peripheral blood biomarkers [6]. Here, CD274 is linked to neoplasm.